Mark Kittipibul MD (@vkittipibul) 's Twitter Profile
Mark Kittipibul MD

@vkittipibul

Cardiology fellow @DukeCardiology & @DCRINews 💙 | @UmJmhIMRes Alum 🙌
MDCU 🇹🇭 |
Aspiring HF Cardiologist | Amateur 👨‍🍳

ID: 1219090723682836483

calendar_today20-01-2020 02:54:21

156 Tweet

664 Followers

407 Following

Steve Greene (@sjgreene_md) 's Twitter Profile Photo

On-treatment analysis of #TRANSFORM_HF led by Mark Kittipibul MD now in European Society of Cardiology Journals #EJHF Among patients adherent to randomized diuretic, no significant difference in outcomes w #torsemide vs #furosemide. Further supports message of original trial results. onlinelibrary.wiley.com/doi/full/10.10…

On-treatment analysis of #TRANSFORM_HF led by <a href="/vkittipibul/">Mark Kittipibul MD</a> now in <a href="/ESC_Journals/">European Society of Cardiology Journals</a> #EJHF

Among patients adherent to randomized diuretic, no significant difference in outcomes w #torsemide vs #furosemide.   Further supports message of original trial results.

onlinelibrary.wiley.com/doi/full/10.10…
Steve Greene (@sjgreene_md) 's Twitter Profile Photo

Terrific work led by Duke Cardiology Fellows Mark Kittipibul MD Many 🏥 and #HF patients continue to struggle w readmissions. Across #RCTs, #SGLT2i significantly reduce both HF and **all-cause** hospitalization, regardless of EF 🔗jacc.org/doi/10.1016/j.… Duke Clinical Research Institute Muthu Vaduganathan

Marat Fudim, MD MHS (@fudimmarat) 's Twitter Profile Photo

🚨 HFSA is now starting: DEVICES IN HEART FAILURE MEETING: FROM MECHANISMS TO IMPLEMENTATION Mark your🗓️ ➡️Friday Sept. 27th. Right before the main #HFSA meeting in #Atlanta hfsa.org/asm/hfsa-devic… 💡Lectures 💡Hands-on sessions 🚀Tech Exhibits 🛜Networking

🚨 <a href="/HFSA/">HFSA</a> is now starting:

DEVICES IN HEART FAILURE MEETING: FROM MECHANISMS TO IMPLEMENTATION

Mark your🗓️ ➡️Friday Sept. 27th. Right before the main #HFSA meeting in #Atlanta

hfsa.org/asm/hfsa-devic…
💡Lectures 
💡Hands-on sessions 
🚀Tech Exhibits 
🛜Networking
Mark Kittipibul MD (@vkittipibul) 's Twitter Profile Photo

Excited to be part of American College of Cardiology cards app mentorship program for 2nd year. Getting paired up with IMG apps made me go back to what I wrote last year on advice for IMG applicants. As J1+ fellow, cant be more grateful for support from Duke Cardiology Fellows tinyurl.com/ys7eu3nk

Robert Mentz, MD (@robmentz) 's Twitter Profile Photo

Duke HF/Transplant recruiting for '25-'26 Fellowship Class! Be part of a world-class transplant/MCS team for an unparalleled trainee experience Highest OHT & VAD volume last yr w excellent pt outcomes & phenomenal trainee teaching Apply via ERAS ✉️PD w ?s: [email protected]

Duke HF/Transplant recruiting for '25-'26 Fellowship Class!
Be part of a world-class transplant/MCS team for an unparalleled trainee experience
Highest OHT &amp; VAD volume last yr w excellent pt outcomes &amp; phenomenal trainee teaching
Apply via ERAS
✉️PD w ?s: richa.agarwal@duke.edu
Laura Cohen (@laurapco) 's Twitter Profile Photo

Heart failure is costly. How does the cost breakdown by EF and can #SGLT2i 💊offset these costs? James Januzzi Jr MD and I explore this in an editorial (🔗tinyurl.com/yvxxvmck) to an excellent paper led by Mark Kittipibul MD, Steve Greene and others. Kudos to the authors #HF #JACCHF

Andrew P. Ambrosy, MD (@kpheartdoc) 's Twitter Profile Photo

Form smart scales to digital biomarkers to improve remote patient monitoring in between discrete clinical encounters (link.springer.com/article/10.100…). Out now in #HREV by Marat Fudim, MD MHS and colleagues. Great overview of emerging tech! Marat Fudim, MD MHS Tor Biering-Sørensen, MD, MSc, MPH, PhD Steve Greene Andrew J Sauer MD

Shahzeb Khan (@shahzebkhanmd) 's Twitter Profile Photo

📝 Cardiac wasting and Cancer in European Society of Cardiology Journals 📌 Cardisc wasting common among pts with cancer 📌 Thin LV and smaller LV size 📌 Potentially an imp endpoint in cardio-oncology trials academic.oup.com/eurheartj/adva…

📝 Cardiac wasting and Cancer in <a href="/ESC_Journals/">European Society of Cardiology Journals</a> 

📌 Cardisc wasting common among pts with cancer

📌 Thin LV and smaller LV size

📌 Potentially an imp endpoint in cardio-oncology trials

academic.oup.com/eurheartj/adva…
Marat Fudim, MD MHS (@fudimmarat) 's Twitter Profile Photo

Finerenone meets primary endpoint in Phase III FINEARTS-HF🎉 ❤️ expanded treatment options for HFpEF! —> to be presented at ESC ‼️pending: the SPIRRT HFPEF trial with MRA ⁦Duke Clinical Research Institute⁩ ⁦Karolinska Institutet⁩ ⁦Uppsala University⁩ ⁦NIH NHLBI⁩ bayer.com/media/en-us/fi…

Novi Tham (@slumberbell) 's Twitter Profile Photo

No matter where you are, #HF is expensive!💸 In the US, HF patients could spend ~$29k annually💰 This study by Mark Kittipibul MD Steve Greene et al found that #SGLT2i not only boosts outcomes across all HF types but also helps patients save💰by ⬇️ 🏥 stays! 🔗:

No matter where you are, #HF is expensive!💸

In the US, HF patients could spend ~$29k annually💰

This study by <a href="/vkittipibul/">Mark Kittipibul MD</a> <a href="/SJGreene_md/">Steve Greene</a> et al found that #SGLT2i not only boosts outcomes across all HF types but also helps patients save💰by ⬇️ 🏥 stays!

🔗:
Marat Fudim, MD MHS (@fudimmarat) 's Twitter Profile Photo

🧵 Tweetorial: Visualizing Lymphatic Flow in Heart Failure Patients Using Indocyanine Green Fluorescence Lymphography pubmed.ncbi.nlm.nih.gov/39170955/ JACC Journals Led by Barbara Ponikowska @Wroclaw_Medical_Univ

🧵 Tweetorial: Visualizing Lymphatic Flow in Heart Failure Patients Using Indocyanine Green Fluorescence Lymphography
pubmed.ncbi.nlm.nih.gov/39170955/
<a href="/JACCJournals/">JACC Journals</a> Led by Barbara Ponikowska @Wroclaw_Medical_Univ
Robert Mentz, MD (@robmentz) 's Twitter Profile Photo

Mechanistic Differences between Torsemide and Furosemide Prospective data debunks classic teachings 🔵No meaningful PK/PD advantages for T 🔵Kidney bioavailability less w T 🔵Ratio T:F was 4:1 (not 2:1!) 🔵T w ⬆️neurohormonal activ & kidney dysfunction journals.lww.com/jasn/abstract/…

Mechanistic Differences between Torsemide and Furosemide

Prospective data debunks classic teachings

🔵No meaningful PK/PD advantages for T
🔵Kidney bioavailability less w T
🔵Ratio T:F was 4:1 (not 2:1!)
🔵T w ⬆️neurohormonal activ &amp; kidney dysfunction

journals.lww.com/jasn/abstract/…
Mark Kittipibul MD (@vkittipibul) 's Twitter Profile Photo

Excited to share our editorial on HF analysis of FLOW trial presented at #ESCCongress2024 & JACC Journals! 🔗tinyurl.com/3tyyf43k 📜tinyurl.com/ud366wpd We discuss how this study fills the gap on GLP1-RA and HF and future research directions. 🙏 to my mentor Robert Mentz, MD!

Excited to share our editorial on HF analysis of FLOW trial presented at #ESCCongress2024  &amp; <a href="/JACCJournals/">JACC Journals</a>!

🔗tinyurl.com/3tyyf43k
📜tinyurl.com/ud366wpd

We discuss how this study fills the gap on GLP1-RA and HF and future research directions.

🙏 to my mentor <a href="/robmentz/">Robert Mentz, MD</a>!